Migraine is a debilitating condition that affects millions of individuals worldwide, often hindering their daily activities and overall quality of life. As researchers continue to explore new treatments, two medications have emerged as notable options for acute migraine relief—Nurtec and Reyvow. These medications belong to different drug classes and offer unique mechanisms of action, which can lead to varied experiences for patients. Understanding the differences and similarities between these two drugs is essential for patients and healthcare professionals alike, as it can help guide treatment decisions and optimize patient outcomes. In the world of migraine management, it’s crucial to consider factors such as efficacy, onset of action, side effects, and…